publication venue for
- Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34+-selected allogeneic transplantation.. 4. 2020
- Dawn of Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma.. 1. 2018
- Method comparison study of peripheral blood CD34+ count performed on an Abbott CELL-DYN Sapphire hematology analyzer versus flow cytometry reference procedure (modified ISHAGE).. 1. 2018